STOCK TITAN

PTC Therapeutics to Participate at Upcoming Investor Conferences

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

PTC Therapeutics, Inc. (NASDAQ: PTCT) has announced its participation in three upcoming investor conferences in September 2024. The company will present overviews at:

  • Morgan Stanley 22nd Annual Global Healthcare Conference on Sept. 5 at 9:15 am ET
  • 2024 Wells Fargo Healthcare Conference on Sept. 6 at 12:00 pm ET
  • Cantor 2024 Global Healthcare Conference on Sept. 17 at 2:30 pm ET

All presentations will be webcast live on PTC Therapeutics' website under the Investor section's Events and Presentations page. The webcasts will remain archived for 30 days after each presentation. Investors are advised to connect to the website several minutes before the start of each webcast to ensure timely access.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

+0.97%
1 alert
+0.97% News Effect

On the day this news was published, PTCT gained 0.97%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WARREN, N.J., Aug. 28, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences:

Morgan Stanley 22nd Annual Global Healthcare Conference
Thursday, Sept. 5 at 9:15 am ET

2024 Wells Fargo Healthcare Conference
Friday, Sept. 6 at 12:00 pm ET

Cantor 2024 Global Healthcare Conference
Tuesday, Sept. 17 at 2:30 pm ET

The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, on X (formerly Twitter), and on LinkedIn.

For More Information:

Investors:
Investor Relations
+1 (908) 912-9848
ir@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

Cision View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-302233405.html

SOURCE PTC Therapeutics, Inc.

FAQ

When is PTC Therapeutics (PTCT) presenting at the Morgan Stanley Healthcare Conference in 2024?

PTC Therapeutics (PTCT) is presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024, at 9:15 am ET.

What investor conferences is PTC Therapeutics (PTCT) attending in September 2024?

PTC Therapeutics (PTCT) is attending three investor conferences in September 2024: Morgan Stanley Global Healthcare Conference, Wells Fargo Healthcare Conference, and Cantor Global Healthcare Conference.

How can investors access PTC Therapeutics' (PTCT) conference presentations in September 2024?

Investors can access PTC Therapeutics' (PTCT) conference presentations via live webcasts on the company's website at https://ir.ptcbio.com/events-presentations. The webcasts will be archived for 30 days after each presentation.

What time is PTC Therapeutics (PTCT) presenting at the 2024 Wells Fargo Healthcare Conference?

PTC Therapeutics (PTCT) is presenting at the 2024 Wells Fargo Healthcare Conference on Friday, September 6, 2024, at 12:00 pm ET.
Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Latest SEC Filings

PTCT Stock Data

6.06B
78.09M
2.47%
101.79%
8.36%
Biotechnology
Pharmaceutical Preparations
Link
United States
WARREN